Vascular artifact mimicking thrombosis on mr imaging using ferumoxytol as a contrast agent in abdominal vascular assessment

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 6, 2014, Pages 969-976

  Fananapazir, Ghaneh ^a   Marin, Daniele ^b   Suhocki, Paul V ^b   Kim, Charles Y ^b   Bashir, Mustafa R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERUMOXYTOL; GADOLINIUM; CONTRAST MEDIUM; MAGNETITE;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL AORTIC DISSECTION; ABSENCE OF SIDE EFFECTS; ADULT; AGED; AORTA DISSECTION; ARTERY DISSECTION; ARTICLE; ARTIFACT MIMICKING THROMBOSIS; BODY MASS; BODY WEIGHT; CELIAC ARTERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; ILIAC ARTERY DISSECTION; IMAGE QUALITY; IN VIVO STUDY; KIDNEY VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULAR DISEASE; VEIN ANEURYSM; VEIN THROMBOSIS; ABDOMEN; ADOLESCENT; ARTERY; ARTIFACT; DIAGNOSTIC USE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; THROMBOSIS; VASCULARIZATION; VEIN; VENOUS THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ABDOMEN; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIES; ARTIFACTS; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THROMBOSIS; VEINS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84901632166     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.12.019     Document Type: Article

References (21)

1. P.H. Kuo, E. Kanal, A.K. Abu-Alfa, and S.E. Cowper Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis Radiology 242 2007 647 649
2. H.S. Thomsen, S.K. Morcos, and T. Almen et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines Eur Radiol 23 2013 307 318
3. M.A. Perazella, and R.F. Reilly Imaging patients with kidney disease: how do we approach contrast-related toxicity? Am J Med Sci 341 2011 215 221
4. Bashir M.R., Mody R., Neville A., et al. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. J Magn Reson Imaging, In press, available online October 15, 2013
5. M.R. Bashir, T.A. Jaffe, T.V. Brennan, U.D. Patel, and M.J. Ellis Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent Transplantation 96 2013 91 96
6. N. Chalouhi, P. Jabbour, V. Magnotta, and D. Hasan The emerging role of ferumoxytol-enhanced MRI in the management of cerebrovascular lesions Molecules (Basel, Switzerland) 18 2013 9670 9683
7. B.S. Spinowitz, A.T. Kausz, and J. Baptista et al. Ferumoxytol for treating iron deficiency anemia in CKD J Am Soc Nephrol 19 2008 1599 1605
8. E.A. Neuwelt, B.E. Hamilton, and C.G. Varallyay et al. Ultrasmall superparamagnetic iron oxides (USPIOs): A future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 75 2009 465 474
9. H. Bernd, E. De Kerviler, S. Gaillard, and B. Bonnemain Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program Invest Radiol 44 2009 336 342
10. K.L. Stabi, and L.M. Bendz Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography Ann Pharmacother 45 2011 1571 1575
11. W. Li, S. Tutton, and A.T. Vu et al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent J Magn Reson Imaging 21 2005 46 52 (Pubitemid 40041419)
12. M. Harisinghani, R.W. Ross, A.R. Guimaraes, and R. Weissleder Utility of a new bolus-injectable nanoparticle for clinical cancer staging Neoplasia (New York, NY) 9 2007 1160 1165 (Pubitemid 350255363)
13. V.S. Lee, D.J. Martin, G.A. Krinsky, and N.M. Rofsky Gadolinium-enhanced MR angiography: Artifacts and pitfalls AJR Am J Roentgenol 175 2000 197 205 (Pubitemid 30415565)
14. E. Dosa, S. Tuladhar, L.L. Muldoon, B.E. Hamilton, W.D. Rooney, and E.A. Neuwelt MRI using ferumoxytol improves the visualization of central nervous system vascular malformations Stroke 42 2011 1581 1588
15. M. Sigovan, W. Gasper, H.F. Alley, C.D. Owens, and D. Saloner USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure Radiology 265 2012 584 590
16. M.R. Prince, H.L. Zhang, S.G. Chabra, P. Jacobs, and Y. Wang A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI J Xray Sci Technol 11 2003 231 240
17. W. Li, J. Salanitri, and S. Tutton et al. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism - preliminary experience Radiology 242 2007 873 881
18. A.T. Tirkes, M.A. Rosen, and E.S. Siegelman Gadolinium susceptibility artifact causing false positive stenosis isolated to the proximal common carotid artery in 3D dynamic contrast medium enhanced MR angiography of the thorax - a brief review of causes and prevention Int J Cardiovasc Imaging 19 2003 151 155 (Pubitemid 36456892)
19. M.A. Neimatallah, T.L. Chenevert, and R.C. Carlos et al. Subclavian MR arteriography: reduction of susceptibility artifact with short echo time and dilute gadopentetate dimeglumine Radiology 217 2000 581 586
20. M. Sasaki, E. Shibata, Y. Kanbara, and S. Ehara Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: A phantom study Magn Reson Med Sci 4 2005 145 149
21. H. Ersoy, P. Jacobs, C.K. Kent, and M.R. Prince Blood pool MR angiography of aortic stent-graft endoleak AJR Am J Roentgenol 182 2004 1181 1186 (Pubitemid 38525510)